Emergent CABG | Elective CABG | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
ICC | IWC | ICC | IWC | |||||||
n | % | n | % | p-Wert | n | % | n | % | p-Wert | |
Age > 70 | 23 | 36.5 | 63 | 36.2 | 45 | 39.8 | 117 | 35.2 | ||
Female gender | 14 | 22.2 | 36 | 20.7 | 0.857 | 24 | 21.2 | 71 | 21.4 | 1.000 |
HT | 49 | 27.8 | 142 | 28.2 | 0.450 | 105 | 59.7 | 295 | 58.3 | 0.279 |
Pulm. HT | 6 | 9.5 | 11 | 6.5 | 0.410 | 4 | 3.5 | 12 | 3.6 | 1.000 |
Hyperlipidemia | 46 | 73.0 | 12 | 65.1 | 0.276 | 92 | 81.4 | 261 | 78.6 | 0.592 |
Diab. mellitus | 16 | 25.4 | 58 | 33.5 | 0.269 | 38 | 33.6 | 134 | 40.4 | 0.220 |
BMI > 30 | 14 | 22.2 | 43 | 24.7 | 0.734 | 42 | 37.2 | 98 | 29.5 | 0.159 |
AF | 14 | 23.7 | 33 | 22.2 | 0.857 | 5 | 4.4 | 20 | 6.0 | 0.641 |
3 V-CAD | 50 | 79.4 | 136 | 78.2 | 1.000 | 97 | 85.8 | 274 | 82.5 | 0.467 |
LMS | 31 | 49.2 | 81 | 47.1 | 0.883 | 39 | 34.5 | 78 | 23.5 | 0.026 |
COPD | 4 | 6.3 | 20 | 11.6 | 0.332 | 15 | 13.3 | 35 | 10.5 | 0.490 |
PAD | 10 | 15.9 | 31 | 17.9 | 0.847 | 20 | 17.7 | 52 | 15.7 | 0.658 |
Smoker | 30 | 47.6 | 91 | 52.9 | 0.556 | 46 | 40.7 | 137 | 41.3 | 1.000 |
Crea >2 | 5 | 7.9 | 11 | 6.3 | 0.770 | 2 | 1.8 | 11 | 3.3 | 0.317 |
CVA | 8 | 12.7 | 31 | 18.0 | 0.429 | 12 | 13.3 | 57 | 17.2 | 0.377 |
Beta-blocker | 48 | 76.2 | 139 | 81.3 | 0.462 | 86 | 76.1 | 274 | 82.5 | 0.165 |
Statin | 42 | 66.7 | 138 | 80.7 | 0.035 | 92 | 81.4 | 256 | 77.1 | 0.359 |
Antiplatel. | 55 | 91.7 | 156 | 94.5 | 0.532 | 26 | 23.0 | 54 | 16.3 | 0.120 |
EF < 40 % | 23 | 36.5 | 48 | 27.6 | 33 | 29.2 | 97 | 29.2 | ||
Euroscore Logistic | 29.82 ± 27.14 | 25.09 ± 23.95 | 0.214 | 7.26 ± 10.91 | 7.20 ± 9.48 | 0.953 |